ANDA 80403, held by Purepac Pharm. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 80403 (Chlorpromazine Hydrochloride), held by Purepac Pharm, was not approved, with 1 approved supplement and 0 published complete response letters.
| Chlorpromazine Hydrochloride25MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride50MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride100MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride10MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Chlorpromazine Hydrochloride200MG · tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 1982 | Supplement 35Manufacturing | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters